Health Robotics to Showcase CytoCare at ISOPP (May 2010) and Charles University' General Faculty Hospital of Prague

BOZEN, Sud-Tirol, Italy, April 26, 2010 /PRNewswire/ -- Health Robotics today announced the upcoming cooperation with the International Society of Oncology Pharmacy Practitioners (ISOPP), B|Braun Melsungen, and the General Faculty Hospital of Prague to host ISOPP delegates at its bi-annual congress to witness live demonstrations of CytoCare in an Oncology patient setting. CytoCare is the only robot in the world proven to compound hazardous sterile I.V. Admixtures. ISOPP 2010 delegates may reserve attendance to this invitation-only event (space limited) at http://www.isopp2010.com/en/health-robotics.

CytoCare directly addresses the challenges of Oncology Pharmacy in the 21st Century, as it has globally set the gold standard of automatically handling the complex and dangerous tasks associated with hazardous CSP (Compounded Sterile Preparations), increasing quality of care, improving patient safety, and decreasing costs, with hospital pharmacy Installations in the United States of America, United Kingdom, Australia, Japan, Malaysia, Taiwan, Germany, Italy, Belgium, Turkey, Saudi Arabia, Denmark, and Czech Republic.

"As we are now approaching 60 global installations of CytoCare, it is indeed a pleasure to share with global ISOPP 2010 delegates the patient and pharmacy safety benefits that academic medical centers such as Charles University's General Faculty Hospital have derived from CytoCare over the last 3 years, especially in contrast with the hype spread by our competitors who after more than 20 years of unsubstantiated announcements[1,2] have yet to even attempt to install a single robot in a hospital pharmacy for chemotherapy use anywhere in the world" stated Werner Rainer, Health Robotics' CEO.

ISOPP 2010 delegates are also invited to visit Health Robotics' booth (F04) at the ISOPP Congress May 5th through May 8th, 2010 and witness presentations and demonstrations of i.v.STATION (robot for adjuvant therapies), OMM (Oncology Medication Management electronic medical record), and i.v.SOFT Assist (workflow engine for manual compounding of chemotherapy IV Admixtures), while Health Robotics' product specialists, European-based staff, and senior management will be available to answer delegates' questions.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding, powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff. For more information, please visit http://www.health-robotics.com

    ---------------------------------
    [1] http://www.intelligenthospitals.com/news-pr-2006-06-26.html
    [2] Am J Hosp Pharm 46(11): 2286-93 1989

    For additional information, please contact:
    Health Robotics S.r.l.
    Claudia Flaim
    Marketing Coordinator
    Italy: +39-0471-200-372
    [email protected]

SOURCE Health Robotics